Koninklijke Philips N.V. PHIA.NV

Headquartered in Amsterdam in the Netherlands, Koninklijke Philips N.V. is a health technology company that develops diagnostics and imaging equipment. The company was established in 1891 and operates in more than 100 countries around the world. In its commitment to driving a sustainable business, the organisation plotted three development goals: promoting the health of all people, addressing sustainability in consumption and production, and actively seeking to remedy climate change. In 2020, Koninklijke Philips received recognition for its attempts to curb climate change.

Koninklijke Philips has three operating divisions: Diagnosis and Treatment, Connected Care, and Personal Health. Its diagnostics and imaging offerings include computed tomography, advanced molecular imaging, diagnostic X-rays, and integrated clinical solutions. Koninklijke Philips also provides digital cloud-based platforms for healthcare providers and healthcare users. These platforms provide information on products, services, and devices.

Koninklijke Philips is publicly listed on the Euronext Amsterdam, where it trades using the ticker PHIA.NV. In February 2021, the company completed its acquisition of BioTelemetry, a US-based provider of cardiac monitoring and diagnostics. This acquisition was worth $2.8bn and will aid the company’s remote care products operations.

Add Koninklijke Philips stock to your eToro watchlist to receive news and updates on the PHIA.NV share price.